Advanced search
Publication Cover
Acta Cardiologica Volume 59, 2004 - Issue 6
Submit an article Journal homepage
11
Views
0
CrossRef citations to date
0
Altmetric
Articles

Cardiovascular prevention in general practice: development and validation of an algorithm

Benoit BolandEpidemiology, Belgium;Internal Medicine, BelgiumCorrespondence[email protected]
,
Régis De MuylderEpidemiology, Belgium
,
Geert GoderisEpidemiology, Belgium
,
Jan DegryseAcademic Centre of General Practice, Katholieke Universiteit Leuven, Belgium
,
Yves GueuningScientific Society of General Practice, Belgium
,
Dominique PaulusGeneral Practice, Université catholique de Louvain;, Belgium
&
Michel JeanjeanEpidemiology, Belgium
 show all
Pages 598-605 | Received 14 Jan 2004, Accepted 29 Apr 2004, Published online: 23 May 2017

References

  • Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, Wang CH. Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N Engl J Med 1998; 339: 861–7.
  • De Henauw S, De Bacquer D, de Smet P, Kornitzer M, De Backer G. Trends in coronary heart disease in two Bel-gian areas: results from the MONICA Ghent-Charleroi study. J Epidemiol Community Health 1999; 53: 89–98.
  • European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J2003; 24: 1601–10.
  • McManus RJ, Mant J, Meulendijks CF, Salter RA, Pattison HM, Roalfe AK, Hobbs FD. Comparison of esti-mates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in gen-eral practice: a cross-sectional study. BMJ 2002; 324: 459–64.
  • Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P for the WHO MONICA Project. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet 1999; 353: 1547–57.
  • Euroaspire II group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 coun-tries: principal results from Euroaspire II. Eur Heart J 2001; 22: 554–72.
  • De Muylder R, Lorant V, Paulus D, Nackers F, Jeanjean M, Boland B. Obstacles to cardiovascular prevention in general practice. Acta Cardiol 2004; 59: 119–25.
  • Robson J, Boomla K, Hart B, Feder G. Estimating cardio-vascular risk for primary prevention: outstanding question for primary care. BMJ 2000; 320, 702–4.
  • World Health Organization-International Society of Hyper-tension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999; 17: 151–83.
  • Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardio-vascular risk profiles. Am Heart J1991; 121: 293–8.
  • WHO MONICA Project principal investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major inter-national collaboration. J Clin Epidemiol 1988; 41: 105–14.
  • Assmann G, Schulte H. Indentification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110: S11–21.
  • Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998; 80: S1–S29.
  • Jones AF, Walker J, Jewkes C, Game FL, Bartlett WA, Marshall T. Comparative accuracy of cardiovascular risk prediction methods in primary care patients. Heart 2001; 85: 37–43.
  • Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley and Sons, 1981.
  • Brohet C, Janssens D, Beck D, Hannut R, Kulbertus H, Lavenne F, Lefebvre P, Rorive G. Cardiovascular risk fac-tors in a sample of a rural Belgian population: the Bellux MONICA study. Acta Med Scand 1998; Suppl 728: 129–36.
  • De Henauw S, De Backer G. Coronair lijden in Belgi6 (coro-nary heart disease in Belgium). Tijdschrift voor Geneeskunde 1995; 51: 1607–16.
  • West of Scotland Coronary Prevention Group. West of Scotland Coronary Prevention study: identification of high-risk groups and comparison with other cardiovascular inter-vention trials. Lancet 1996; 348: 1339–42.
  • Brindle P, Emberson J, Lampe F, Walker M, Whincup P, Fahey T, Ebrahim S. Predictive accuracy of the Framing-ham coronary risk score in British men: prospective cohort study. BMJ 2003; 327: 1267–70.
  • Hermanson B, Omenn GS, Kronmal RA, Gersh BJ. Bene-ficial six-year outcome of smoking cessation in older men and women with coronary artery disease. N Engl J Med 1988; 319: 1365–9.
  • de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Cir-culation 1999; 99: 779–85.
  • Blair SN, Kohl HW, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all cause mortality. A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093–8.
  • Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of anti-platelet therapy for pre-vention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71–86.
  • Heart Protection Study Collaborative Group. MCR/BHF Heart Protection Study of cholesterol lowering with sim-vastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7–22.
  • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on CV events in high-risk patients. The Heart Out-comes Prevention Evaluation Study investigators. N Engl J Med 2000; 342: 145–53.
  • Stratton IM, Adler AT, Neil HA, Matthews DR, Manley SE, Cull CA. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000; 321: 405–12.
  • Sixth report of the Joint National Committee on preven-tion, detection, evaluation and treatment of high blood pres-sure. Arch Intern Med 1997; 157: 2413–46.
  • Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of Euro-pean and other Societies on coronary prevention. Eur Heart J1998; 19: 1434–503.
  • Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care 2000; 23: 1499–504.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.